GlassScriptPhysician profile
Sonja B Woods
NPI 1104853639
$6,130.10
in general payments reported to CMS, 2019-2025
39 companies · $556 in 2025
The $556 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,012 · 2020: $988 · 2021: $825 · 2022: $1,020 · 2023: $846 · 2024: $882 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,284.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $814.61 | 2019-2025 | |
| Novo Nordisk INC | $717.91 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $595.75 | 2021-2025 | Vraylar, Ubrelvy |
| Lilly USA, LLC | $512.46 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $431.35 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $275.50 | 2019-2024 | Farxiga, Breztri |
| Allergan, INC. | $273.90 | 2019-2020 | |
| Amgen INC. | $243.22 | 2019-2025 | Repatha, Otezla, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $240.16 | 2022-2025 | |
| Glaxosmithkline, LLC. | $235.03 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $214.79 | 2019-2025 | Capvaxive, Gardasil, Gardasil 9 |
| Novartis Pharmaceuticals Corporation | $214.02 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $189.04 | 2020-2025 | Xifaxan |
| Amarin Pharma, INC. | $158.67 | 2019-2021 | |
| Dexcom, INC. | $106.87 | 2021-2025 | Dexcom G6 Transmitter |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonja Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.